Crovalimab, Crovalimab, Crovalimab Placebo F01-01, Crovalimab
BP39144
Phase 2 small_molecule active
Quick answer
Crovalimab, Crovalimab, Crovalimab Placebo F01-01, Crovalimab for Paroxysmal nocturnal hemoglobinuria (PNH) is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Paroxysmal nocturnal hemoglobinuria (PNH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active